Exer AI

Exer AI is a pioneering company specializing in Clinical AI solutions that enhance patient care through precise motion assessments using AI technology, enabling healthcare providers to optimize treatment plans and improve patient outcomes. Founded in 2019 and headquartered in Denver, US, Exer AI creates innovative solutions in the healthcare technology sector. The company has successfully raised USD 6. 5 mn in funding through its latest round on November 3, 2022, attracting several new investors including Backstage Capital and Life Extension Ventures, and bringing the total amount raised to USD 6.

5 mn. The company has completed two deals to date, driving its mission to improve clinical decision-making. Exer AI specializes in providing a Clinical AI platform designed to enhance patient care through objective motion assessments. Their core product leverages AI-powered motion insights to deliver real-time movement data, allowing healthcare providers to create personalized treatment plans across various medical domains, including orthopedics, neurology, and senior care.

The platform operates seamlessly without the need for wearables or sensors, offering solutions for early detection of movement changes, fall prevention, and rehabilitation strategies. This innovative technology is utilized by healthcare professionals in diverse settings, including clinics, telehealth environments, and home care, thereby targeting a wide patient demographic. Exer AI's solutions are primarily deployed in the United States and regions with advanced healthcare infrastructures. Exer AI generates revenue through a subscription-based model, wherein healthcare providers access their Clinical AI platform for real-time motion analysis and clinical decision support.

Clients, which include orthopedic specialists, rehabilitation centers, and senior care facilities, pay for tiered subscription plans that provide varying levels of access to the platform's functionalities. The business transactions typically involve ongoing partnerships where clients integrate Exer AI's services into their existing workflows, enhancing patient management and care coordination while optimizing operational costs. Specific pricing plans are structured around the spectrum of services offered, catering to individual practice needs and ensuring that providers can scale their usage as required. Exer AI intends to leverage the USD 6.

5 mn raised in November 2022 to enhance its Clinical AI platform and expand its offerings. The company is actively working on launching new features designed to further improve patient engagement and care quality, with specific rollout dates yet to be disclosed. Additionally, Exer AI plans to broaden its market presence by targeting expansion into Europe and Asia by 2024, aiming to provide its innovative solutions to a wider audience of healthcare practitioners.